{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:33:01Z","timestamp":1793773981581,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Rheumatoid arthritis (RA) is one of the most prevalent and debilitating joint diseases worldwide. RA is characterized by synovial inflammation (synovitis), which is linked to the development of joint destruction. Magnetic resonance imaging and ultrasonography are widely being used to detect the presence and extent of synovitis. However, these techniques do not reveal the activation status of inflammatory cells such as macrophages that play a crucial role in synovitis and express CD64 (Fc gamma receptor (Fc\u03b3R)I) which is considered as macrophage activation marker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to investigate CD64 expression and its correlation with pro-inflammatory cytokines and pro-damaging factors in human-derived RA synovium. Furthermore, we aimed to set up a molecular imaging modality using a radiolabeled CD64-specific antibody as a novel imaging tracer that could be used to determine the extent and phenotype of synovitis using optical and nuclear imaging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>First, we investigated CD64 expression in synovium of early- and late-stage RA patients and studied its correlation with the expression of pro-inflammatory and tissue-damaging factors. Next, we conjugated an anti-CD64 antibody with IRDye 800CW and diethylenetriamine penta-acetic acid (DTPA; used for<jats:sup>111<\/jats:sup>In labeling) and tested its binding on cultured THP1 cells, ex vivo RA synovium explants and its imaging potential in SCID mice implanted with human RA synovium explants obtained from RA patients who underwent total joint replacement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We showed that CD64 is expressed in synovium of early and late-stage RA patients and that<jats:italic>FCGR1A<\/jats:italic>\/CD64 expression is strongly correlated with factors known to be involved in RA progression. Combined, this makes CD64 a useful marker for imaging the extent and phenotype of synovitis. We reported higher binding of the [<jats:sup>111<\/jats:sup>In]In-DTPA-IRDye 800CW anti-CD64 antibody to in vitro cultured THP1 monocytes and ex vivo RA synovium compared to isotype control. In human RA synovial explants implanted in SCID mice, the ratio of uptake of the antibody in synovium over blood was significantly higher when injected with anti-CD64 compared to isotype and injecting an excess of unlabeled antibody significantly reduced the antibody-binding associated signal, both indicating specific receptor binding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Taken together, we successfully developed an optical and nuclear imaging modality to detect CD64 in human RA synovium in vivo.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-023-03147-y","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T08:02:20Z","timestamp":1693468940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis"],"prefix":"10.1186","volume":"25","author":[{"given":"Wessel F.","family":"Theeuwes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Di Ceglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne N.","family":"Dorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen B.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree L.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander W.","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Jimenez-Royo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"van der Kraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Laverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije I.","family":"Koenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"van Lent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn H. J.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"6","key":"3147_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64(6):834\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3147_CR2","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/ar2478","volume":"10","author":"X Zhao","year":"2008","unstructured":"Zhao X, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):R94.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3147_CR3","doi-asserted-by":"publisher","first-page":"R132","DOI":"10.1186\/ar3070","volume":"12","author":"K Van Steendam","year":"2010","unstructured":"Van Steendam K, et al. Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins. Arthritis Res Ther. 2010;12(4):R132.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3147_CR4","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/ar1926","volume":"8","author":"L Mathsson","year":"2006","unstructured":"Mathsson L, et al. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res Ther. 2006;8(3):R64.","journal-title":"Arthritis Res Ther"},{"key":"3147_CR5","doi-asserted-by":"crossref","unstructured":"Akinrinmade OA, et al. CD64: An attractive immunotherapeutic target for M1-type macrophage mediated chronic inflammatory diseases. Biomedicines. 2017;5(3):56.","DOI":"10.3390\/biomedicines5030056"},{"issue":"3","key":"3147_CR6","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/ar2206","volume":"9","author":"SE Magnusson","year":"2007","unstructured":"Magnusson SE, et al. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis. Arthritis Res Ther. 2007;9(3):R51.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3147_CR7","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/S0002-9440(10)63081-7","volume":"159","author":"PL van Lent","year":"2001","unstructured":"van Lent PL, et al. Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis. Am J Pathol. 2001;159(6):2309\u201320.","journal-title":"Am J Pathol"},{"issue":"1","key":"3147_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0002-9440(10)64379-9","volume":"160","author":"LS Davis","year":"2002","unstructured":"Davis LS, et al. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am J Pathol. 2002;160(1):357\u201367.","journal-title":"Am J Pathol"},{"issue":"6","key":"3147_CR9","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/art.34352","volume":"64","author":"MI Koenders","year":"2012","unstructured":"Koenders MI, et al. T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization. Arthritis Rheum. 2012;64(6):1762\u201370.","journal-title":"Arthritis Rheum"},{"key":"3147_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2191-219X-2-4","volume":"2","author":"M Brom","year":"2012","unstructured":"Brom M, et al. Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer. EJNMMI Res. 2012;2:4.","journal-title":"EJNMMI Res"},{"key":"3147_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102923","volume":"133","author":"TA de Jong","year":"2022","unstructured":"de Jong TA, et al. Synovial gene signatures associated with the development of rheumatoid arthritis in at risk individuals: A prospective study. J Autoimmun. 2022;133: 102923.","journal-title":"J Autoimmun"},{"issue":"6","key":"3147_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jlb.49.6.556","volume":"49","author":"HB Fleit","year":"1991","unstructured":"Fleit HB, Kobasiuk CD. The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII. J Leukoc Biol. 1991;49(6):556\u201365.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"3147_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137474","volume":"10","author":"P Matt","year":"2015","unstructured":"Matt P, Lindqvist U, Kleinau S. Elevated membrane and soluble CD64: a novel marker reflecting altered FcgammaR function and disease in early rheumatoid arthritis that can be regulated by anti-rheumatic treatment. PLoS ONE. 2015;10(9): e0137474.","journal-title":"PLoS ONE"},{"issue":"6","key":"3147_CR14","first-page":"1037","volume":"20","author":"P Minar","year":"2014","unstructured":"Minar P, et al. Utility of neutrophil Fcgamma receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn\u2019s disease. Inflamm Bowel Dis. 2014;20(6):1037\u201348.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3147_CR15","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/ar2590","volume":"11","author":"Y Li","year":"2009","unstructured":"Li Y, et al. Increased expression of FcgammaRI\/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther. 2009;11(1):R6.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3147_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/19420862.2015.1066950","volume":"7","author":"D Hristodorov","year":"2015","unstructured":"Hristodorov D, et al. Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies. MAbs. 2015;7(5):853\u201362.","journal-title":"MAbs"},{"issue":"8","key":"3147_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/ard.2006.064741","volume":"66","author":"HB Hammer","year":"2007","unstructured":"Hammer HB, et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis. 2007;66(8):1093\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3147_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3899\/jrheum.150998","volume":"43","author":"PS Patro","year":"2016","unstructured":"Patro PS, et al. Myeloid-related protein 8\/14 levels in rheumatoid arthritis: marker of disease activity and response to methotrexate. J Rheumatol. 2016;43(4):731\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"3147_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/ard.2008.103739","volume":"69","author":"HB Hammer","year":"2010","unstructured":"Hammer HB, et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):150\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3147_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13075-016-1201-0","volume":"19","author":"HH Nordal","year":"2017","unstructured":"Nordal HH, et al. Calprotectin (S100A8\/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):3.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3147_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000654","volume":"4","author":"L Tweehuysen","year":"2018","unstructured":"Tweehuysen L, et al. Predictive value of serum calprotectin (S100A8\/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis. RMD Open. 2018;4(1): e000654.","journal-title":"RMD Open"},{"issue":"3","key":"3147_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2013-203923","volume":"74","author":"IY Choi","year":"2015","unstructured":"Choi IY, et al. MRP8\/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74(3):499\u2013505.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3147_CR23","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1093\/rheumatology\/keu254","volume":"53","author":"M Xue","year":"2014","unstructured":"Xue M, et al. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation. Rheumatology (Oxford). 2014;53(12):2270\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3147_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/ar79","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, et al. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res. 2000;2(2):145\u201353.","journal-title":"Arthritis Res"},{"issue":"1","key":"3147_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/rheumatology\/keg037","volume":"42","author":"MJ Green","year":"2003","unstructured":"Green MJ, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford). 2003;42(1):83\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"3147_CR26","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1002\/art.22964","volume":"56","author":"CA Wijbrandts","year":"2007","unstructured":"Wijbrandts CA, et al. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum. 2007;56(11):3869\u201371.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3147_CR27","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/ar3682","volume":"14","author":"C Fueldner","year":"2012","unstructured":"Fueldner C, et al. Identification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry. Arthritis Res Ther. 2012;14(1):R8.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3147_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/ard.2004.028845","volume":"64","author":"JA van Roon","year":"2005","unstructured":"van Roon JA, et al. Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate. Ann Rheum Dis. 2005;64(6):865\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3147_CR29","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/art.10940","volume":"48","author":"JA van Roon","year":"2003","unstructured":"van Roon JA, et al. Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis by an Fcgamma receptor I-directed immunotoxin. Arthritis Rheum. 2003;48(5):1229\u201338.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3147_CR30","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.4049\/jimmunol.176.10.5833","volume":"176","author":"AJ van Vuuren","year":"2006","unstructured":"van Vuuren AJ, et al. CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model. J Immunol. 2006;176(10):5833\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"3147_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1189\/jlb.2AB0713-372R","volume":"96","author":"J Shen","year":"2014","unstructured":"Shen J, et al. Folate receptor-beta constitutes a marker for human proinflammatory monocytes. J Leukoc Biol. 2014;96(4):563\u201370.","journal-title":"J Leukoc Biol"},{"issue":"16","key":"3147_CR32","doi-asserted-by":"publisher","first-page":"14700","DOI":"10.18632\/oncotarget.3739","volume":"6","author":"J Shen","year":"2015","unstructured":"Shen J, et al. Assessment of folate receptor-beta expression in human neoplastic tissues. Oncotarget. 2015;6(16):14700\u20139.","journal-title":"Oncotarget"},{"issue":"10","key":"3147_CR33","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1182\/blood.V96.10.3529","volume":"96","author":"H Wang","year":"2000","unstructured":"Wang H, et al. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia. Blood. 2000;96(10):3529\u201336.","journal-title":"Blood"},{"key":"3147_CR34","unstructured":"Lewis MJ, et al. Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes. Cell Rep. 2019;28(9):2455\u20132470 e5."},{"issue":"2","key":"3147_CR35","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/ar4191","volume":"15","author":"YY Gent","year":"2013","unstructured":"Gent YY, et al. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Arthritis Res Ther. 2013;15(2):R37.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3147_CR36","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41598-020-57841-x","volume":"10","author":"NJF Verweij","year":"2020","unstructured":"Verweij NJF, et al. First in man study of [(18)F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis. Sci Rep. 2020;10(1):1047.","journal-title":"Sci Rep"},{"issue":"5","key":"3147_CR37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/art.40428","volume":"70","author":"DE Orange","year":"2018","unstructured":"Orange DE, et al. Identification of three rheumatoid arthritis disease subtypes by machine learning integration of synovial histologic features and RNA sequencing data. Arthritis Rheumatol. 2018;70(5):690\u2013701.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"3147_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11307-007-0113-4","volume":"9","author":"EH Elzinga","year":"2007","unstructured":"Elzinga EH, et al. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol. 2007;9(6):357\u201360.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"3147_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar4542","volume":"16","author":"S Put","year":"2014","unstructured":"Put S, et al. Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques. Arthritis Res Ther. 2014;16(2):208.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3147_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF03164932","volume":"13","author":"M Sahin","year":"1999","unstructured":"Sahin M, et al. Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants. Ann Nucl Med. 1999;13(6):389\u201395.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"3147_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ajg.2008.6","volume":"104","author":"W Tillinger","year":"2009","unstructured":"Tillinger W, et al. Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics. Am J Gastroenterol. 2009;104(1):102\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"3147_CR42","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar3017","volume":"12","author":"Y Li","year":"2010","unstructured":"Li Y, et al. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(3):R90.","journal-title":"Arthritis Res Ther"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03147-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T06:49:26Z","timestamp":1730011766000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03147-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3147"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03147-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"From early RA patients, synovium biopsies were collected by routinely performed mini-arthroscopic tissue sampling of a knee joint after informed consent and in accordance with the principles of the Declaration of Helsinki. The human biological samples were sourced ethically and their research use was in accordance with the terms of the informed consents under an IRB\/EC-approved protocol. All animal experiments were conducted according to Dutch law and approved by the Dutch Central Authority for Scientific Procedures on Animals (AVD 103002016786 and AVD 10300202010389). All animal studies were ethically reviewed and carried out in accordance with European Directive 2010\/63\/EEC and the GSK Policy on the Care, Welfare and Treatment of Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}